Clinical trial
Lemborexant for Insomnia in a Patient With Dementia: An N-of-1 Trial
NCT06093126 is registered in ClinicalTrials.gov with Nova Scotia Health Authority as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Lemborexant for Insomnia in a Patient With Dementia: An N-of-1 Trial
- Lead sponsor
- Nova Scotia Health Authority
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- December 11, 2023
- Completion date
- December 11, 2028
- Enrollment
- 1 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dementia, frontotemporal dementia, insomnia